Figure 2.
Possible temperature–composition phase diagrams for a drug–polymer solid dispersion showing (A) the situation where an amorphous phase separation curve does not interact with the glass transition temperature curve and (B) the situation where the amorphous phase separation curve interacts with the glass transition temperature curve.
